Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix
The Prostate · 2024
DOI: 10.1002/pros.24679 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2024. Verfasst von Shuhei Kamada und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan. Hauptthemen laut MEDLINE: Testosterone, Prostatic Neoplasms, Oligopeptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan China Sasakawa Medical Fellowship (to X. Z.).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
To clarify the clinical roles of changes in testosterone (T) levels with a cut‐off level of 20 ng/dL as predictive factors for prostate cancer patients treated with degarelix acetate.
Methods
A total of 120 prostate cancer patients who received hormone therapies with gonadotropin‐releasing hormone antagonist degarelix acetate were retrospectively analyzed. The predictive values of nadir T levels, max T levels, T bounce, and other clinical factors were evaluated for overall survival (OS), cancer‐specific survival (CSS), and progression‐free survival (PFS). T bounce was defined as satisfying both nadir serum T levels of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
- Department of Urology, Saiseikai Utsunomiya Hospital, Utsunomiya, Japan.
- Department of Urology, Funabashi Municipal Medical Center, Funabashi, Japan.
- Department of Urology, Kanazawa Medical University, Kahoku-gun, Japan.
- Department of Urology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
- Department of Urology, Toho University Sakura Medical Center, Sakura, Japan.
ORCID-Profile: Shuhei Kamada, Shinichi Sakamoto, Rii Junryo, Yasutaka Yamada, Atsushi Mizokami
Förderung
- Japan Society for the Promotion of Science
- Japan China Sasakawa Medical Fellowship (to X. Z.)
Zitieren
APA
Kamada, S., Sakamoto, S., Kinoshita, R., Zhao, X., Kamasako, T., Yamase, R., Junryo, R., Saito, S., Sangjon, P., Takei, A., Yamada, Y., Goto, Y., Imamura, Y., Iguchi, T., Mizokami, A., Suzuki, H., Akakura, K., & Ichikawa, T. (2024). Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix. The Prostate. https://doi.org/10.1002/pros.24679
Vancouver
Kamada S, Sakamoto S, Kinoshita R, Zhao X, Kamasako T, Yamase R, et al. Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix. The Prostate. 2024. doi:10.1002/pros.24679
BibTeX
@article{Kamada2024,
author = {Kamada, Shuhei and Sakamoto, Shinichi and Kinoshita, Ryo and Zhao, Xue and Kamasako, Tomohiko and Yamase, Ryosuke and Junryo, Rii and Saito, Shinpei and Sangjon, Pae and Takei, Akinori and Yamada, Yasutaka and Goto, Yusuke and Imamura, Yusuke and Iguchi, Taro and Mizokami, Atsushi and Suzuki, Hiroyoshi and Akakura, Koichiro and Ichikawa, Tomohiko},
title = {Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix},
journal = {The Prostate},
year = {2024},
doi = {10.1002/pros.24679}
}
EUVIMED